Minotti G, Licata S, Saponiero A, Menna P, Calafiore A M, Di Giammarco G, Liberi G, Animati F, Cipollone A, Manzini S, Maggi C A
Department of Drug Sciences, G. D'Annunzio University School of Pharmacy, and Department of Cardiac Surgery, G. D'Annunzio University School of Medicine, Chieti, Italy.
Chem Res Toxicol. 2000 Dec;13(12):1336-41. doi: 10.1021/tx000143z.
Secondary alcohol metabolites have been proposed to mediate chronic cardiotoxicity induced by doxorubicin (DOX) and other anticancer anthracyclines. In this study, NADPH-supplemented human cardiac cytosol was found to reduce the carbonyl group in the side chain of the tetracyclic ring of DOX, producing the secondary alcohol metabolite doxorubicinol (DOXol). A decrease in the level of alcohol metabolite formation was observed by replacing DOX with epirubicin (EPI), a less cardiotoxic analogue characterized by an axial-to-equatorial epimerization of the hydroxyl group at C-4 in the amino sugar bound to the tetracyclic ring (daunosamine). A similar decrease was observed by replacing DOX with MEN 10755, a novel anthracycline with preclinical evidence of reduced cardiotoxicity. MEN 10755 is characterized by the lack of a methoxy group at C-4 in the tetracyclic ring and by intercalation of 2, 6-dideoxy-L-fucose between daunosamine and the aglycone. Multiple comparisons with methoxy- or 4-demethoxyaglycones, and a number of mono- or disaccharide 4-demethoxyanthracyclines, showed that both the lack of the methoxy group and the presence of a disaccharide moiety limited alcohol metabolite formation by MEN 10755. Studies with enzymatically generated or purified anthracycline secondary alcohols also showed that the presence of a disaccharide moiety, but not the lack of a methoxy group, made the metabolite of MEN 10755 less reactive with the [4Fe-4S] cluster of cytoplasmic aconitase, as evidenced by its limited reoxidation to the parent carbonyl anthracycline and by a reduced level of delocalization of Fe(II) from the cluster. Collectively, these studies (i) characterize the different influence of methoxy and sugar substituents on the formation and [4Fe-4S] reactivity of anthracycline secondary alcohols, (ii) lend support to the role of alcohol metabolites in anthracycline-induced cardiotoxicity, as they demonstrate that the less cardiotoxic EPI and MEN 10755 share a reduction in the level of formation of such metabolites, and (iii) suggest that the cardiotoxicity of MEN 10755 might be further decreased by the reduced [4Fe-4S] reactivity of its alcohol metabolite.
仲醇代谢产物被认为可介导阿霉素(DOX)和其他抗癌蒽环类药物引起的慢性心脏毒性。在本研究中,发现补充烟酰胺腺嘌呤二核苷酸磷酸(NADPH)的人心脏胞质溶胶可还原DOX四环环侧链中的羰基,生成仲醇代谢产物阿霉素醇(DOXol)。通过用表柔比星(EPI)替代DOX观察到醇代谢产物生成水平降低,EPI是一种心脏毒性较小的类似物,其特征在于与四环环(柔红糖胺)结合的氨基糖中C-4位的羟基发生轴向至赤道的差向异构化。用MEN 10755替代DOX也观察到类似的降低,MEN 10755是一种新型蒽环类药物,临床前证据表明其心脏毒性降低。MEN 10755的特征在于四环环中C-4位没有甲氧基,并且在柔红糖胺和苷元之间插入了2,6-二脱氧-L-岩藻糖。与甲氧基或4-去甲氧基苷元以及一些单糖或双糖4-去甲氧基蒽环类药物进行的多重比较表明,甲氧基的缺失和双糖部分的存在均限制了MEN 10755的醇代谢产物形成。对酶促生成或纯化的蒽环类仲醇的研究还表明,双糖部分的存在而非甲氧基的缺失使MEN 10755的代谢产物与细胞质乌头酸酶的[4Fe-4S]簇的反应性降低,这表现为其还原为母体羰基蒽环类药物的程度有限以及Fe(II)从簇中离域的水平降低。总体而言,这些研究(i)表征了甲氧基和糖取代基对蒽环类仲醇形成和[4Fe-4S]反应性的不同影响,(ii)支持醇代谢产物在蒽环类药物诱导的心脏毒性中的作用,因为它们表明心脏毒性较小的EPI和MEN 10755在此类代谢产物形成水平上均有所降低,并且(iii)表明MEN 10755的心脏毒性可能因其醇代谢产物的[4Fe-4S]反应性降低而进一步降低。